Literature DB >> 24907273

Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells.

Matthew C Canver1, Daniel E Bauer2, Abhishek Dass3, Yvette Y Yien4, Jacky Chung4, Takeshi Masuda5, Takahiro Maeda4, Barry H Paw6, Stuart H Orkin7.   

Abstract

The clustered regularly interspaced short [corrected] palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 nuclease system has provided a powerful tool for genome engineering. Double strand breaks may trigger nonhomologous end joining repair, leading to frameshift mutations, or homology-directed repair using an extrachromosomal template. Alternatively, genomic deletions may be produced by a pair of double strand breaks. The efficiency of CRISPR/Cas9-mediated genomic deletions has not been systematically explored. Here, we present a methodology for the production of deletions in mammalian cells, ranging from 1.3 kb to greater than 1 Mb. We observed a high frequency of intended genomic deletions. Nondeleted alleles are nonetheless often edited with inversions or small insertion/deletions produced at CRISPR recognition sites. Deleted alleles also typically include small insertion/deletions at predicted deletion junctions. We retrieved cells with biallelic deletion at a frequency exceeding that of probabilistic expectation. We demonstrate an inverse relationship between deletion frequency and deletion size. This work suggests that CRISPR/Cas9 is a robust system to produce a spectrum of genomic deletions to allow investigation of genes and genetic elements.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CRISPR; Cas9; Gene Expression; Gene Knock-out; Gene Regulation; Genetics; Genome Engineering; Genomic Deletion; Genomics

Mesh:

Year:  2014        PMID: 24907273      PMCID: PMC4118095          DOI: 10.1074/jbc.M114.564625

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis.

Authors:  Xiaogang Guo; Tiejun Zhang; Zheng Hu; Yanqi Zhang; Zhaoying Shi; Qinhu Wang; Yan Cui; Fengqin Wang; Hui Zhao; Yonglong Chen
Journal:  Development       Date:  2014-01-08       Impact factor: 6.868

2.  Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting.

Authors:  Jiankui Zhou; Jianying Wang; Bin Shen; Li Chen; Yang Su; Jing Yang; Wensheng Zhang; Xuemei Tian; Xingxu Huang
Journal:  FEBS J       Date:  2014-02-26       Impact factor: 5.542

3.  High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells.

Authors:  Yuexin Zhou; Shiyou Zhu; Changzu Cai; Pengfei Yuan; Chunmei Li; Yanyi Huang; Wensheng Wei
Journal:  Nature       Date:  2014-04-09       Impact factor: 49.962

4.  Genome-scale CRISPR-Cas9 knockout screening in human cells.

Authors:  Ophir Shalem; Neville E Sanjana; Ella Hartenian; Xi Shi; David A Scott; Tarjei Mikkelson; Dirk Heckl; Benjamin L Ebert; David E Root; John G Doench; Feng Zhang
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

5.  Correction of a genetic disease in mouse via use of CRISPR-Cas9.

Authors:  Yuxuan Wu; Dan Liang; Yinghua Wang; Meizhu Bai; Wei Tang; Shiming Bao; Zhiqiang Yan; Dangsheng Li; Jinsong Li
Journal:  Cell Stem Cell       Date:  2013-12-05       Impact factor: 24.633

6.  Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.

Authors:  Gerald Schwank; Bon-Kyoung Koo; Valentina Sasselli; Johanna F Dekkers; Inha Heo; Turan Demircan; Nobuo Sasaki; Sander Boymans; Edwin Cuppen; Cornelis K van der Ent; Edward E S Nieuwenhuis; Jeffrey M Beekman; Hans Clevers
Journal:  Cell Stem Cell       Date:  2013-12-05       Impact factor: 24.633

7.  Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.

Authors:  Yuyu Niu; Bin Shen; Yiqiang Cui; Yongchang Chen; Jianying Wang; Lei Wang; Yu Kang; Xiaoyang Zhao; Wei Si; Wei Li; Andy Peng Xiang; Jiankui Zhou; Xuejiang Guo; Ye Bi; Chenyang Si; Bian Hu; Guoying Dong; Hong Wang; Zuomin Zhou; Tianqing Li; Tao Tan; Xiuqiong Pu; Fang Wang; Shaohui Ji; Qi Zhou; Xingxu Huang; Weizhi Ji; Jiahao Sha
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

Review 8.  CRISPR/Cas9 and genome editing in Drosophila.

Authors:  Andrew R Bassett; Ji-Long Liu
Journal:  J Genet Genomics       Date:  2013-12-18       Impact factor: 4.275

9.  Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification.

Authors:  John P Guilinger; David B Thompson; David R Liu
Journal:  Nat Biotechnol       Date:  2014-04-25       Impact factor: 54.908

10.  Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.

Authors:  Yanfang Fu; Jeffry D Sander; Deepak Reyon; Vincent M Cascio; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-01-26       Impact factor: 54.908

View more
  163 in total

Review 1.  Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.

Authors:  Mehmet Fatih Bolukbasi; Ankit Gupta; Scot A Wolfe
Journal:  Nat Methods       Date:  2016-01       Impact factor: 28.547

2.  EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.

Authors:  Aline Renneville; Peter Van Galen; Matthew C Canver; Marie McConkey; John M Krill-Burger; David M Dorfman; Edward B Holson; Bradley E Bernstein; Stuart H Orkin; Daniel E Bauer; Benjamin L Ebert
Journal:  Blood       Date:  2015-08-28       Impact factor: 22.113

3.  Efficient, complete deletion of synaptic proteins using CRISPR.

Authors:  Salvatore Incontro; Cedric S Asensio; Robert H Edwards; Roger A Nicoll
Journal:  Neuron       Date:  2014-08-21       Impact factor: 17.173

4.  TMEM14C is required for erythroid mitochondrial heme metabolism.

Authors:  Yvette Y Yien; Raymond F Robledo; Iman J Schultz; Naoko Takahashi-Makise; Babette Gwynn; Daniel E Bauer; Abhishek Dass; Gloria Yi; Liangtao Li; Gordon J Hildick-Smith; Jeffrey D Cooney; Eric L Pierce; Kyla Mohler; Tamara A Dailey; Non Miyata; Paul D Kingsley; Caterina Garone; Shilpa M Hattangadi; Hui Huang; Wen Chen; Ellen M Keenan; Dhvanit I Shah; Thorsten M Schlaeger; Salvatore DiMauro; Stuart H Orkin; Alan B Cantor; James Palis; Carla M Koehler; Harvey F Lodish; Jerry Kaplan; Diane M Ward; Harry A Dailey; John D Phillips; Luanne L Peters; Barry H Paw
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

5.  Target specificity of the CRISPR-Cas9 system.

Authors:  Xuebing Wu; Andrea J Kriz; Phillip A Sharp
Journal:  Quant Biol       Date:  2014-06

6.  The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability.

Authors:  Jacky Chung; Daniel E Bauer; Alireza Ghamari; Christopher P Nizzi; Kathryn M Deck; Paul D Kingsley; Yvette Y Yien; Nicholas C Huston; Caiyong Chen; Iman J Schultz; Arthur J Dalton; Johannes G Wittig; James Palis; Stuart H Orkin; Harvey F Lodish; Richard S Eisenstein; Alan B Cantor; Barry H Paw
Journal:  Sci Signal       Date:  2015-04-14       Impact factor: 8.192

7.  A CRISPR/Cas9 library to map the HIV-1 provirus genetic fitness.

Authors:  K E Yoder
Journal:  Acta Virol       Date:  2019       Impact factor: 1.162

8.  CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions.

Authors:  Molly Gasperini; Gregory M Findlay; Aaron McKenna; Jennifer H Milbank; Choli Lee; Melissa D Zhang; Darren A Cusanovich; Jay Shendure
Journal:  Am J Hum Genet       Date:  2017-07-14       Impact factor: 11.025

9.  MLKL Requires the Inositol Phosphate Code to Execute Necroptosis.

Authors:  Cole M Dovey; Jonathan Diep; Bradley P Clarke; Andrew T Hale; Dan E McNamara; Hongyan Guo; Nathaniel W Brown; Jennifer Yinuo Cao; Christy R Grace; Peter J Gough; John Bertin; Scott J Dixon; Dorothea Fiedler; Edward S Mocarski; William J Kaiser; Tudor Moldoveanu; John D York; Jan E Carette
Journal:  Mol Cell       Date:  2018-06-07       Impact factor: 17.970

10.  Hematopoietic stem cells develop in the absence of endothelial cadherin 5 expression.

Authors:  Heidi Anderson; Taylor C Patch; Pavankumar N G Reddy; Elliott J Hagedorn; Peter G Kim; Kathleen A Soltis; Michael J Chen; Owen J Tamplin; Maike Frye; Glenn A MacLean; Kathleen Hübner; Daniel E Bauer; John P Kanki; Guillaume Vogin; Nicholas C Huston; Minh Nguyen; Yuko Fujiwara; Barry H Paw; Dietmar Vestweber; Leonard I Zon; Stuart H Orkin; George Q Daley; Dhvanit I Shah
Journal:  Blood       Date:  2015-09-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.